NCT05995769 Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder Status RECRUITING Phase PHASE2
NCT05947383 Two Doses of Psilocybin for the Treatment of MDD in Adults With Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05876481 Evaluation of Psilocybin-assisted Psychotherapy (PaP) for the Treatment of Post-traumatic Stress Disorder (PTSD) in Military Veterans Status UNKNOWN Phase PHASE2
NCT05847686 Psilocybin-Assisted Therapy for the Treatment of Cancer-Related Anxiety in Patients With Metastatic Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT05733546 A Phase II, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of COMP360 in Participants With Recurrent Major Depressive Disorder Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05711940 Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05698511 Neural and Physiological Correlates of Psychedelic Sub-states Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05646303 Psilocybin-Assisted Psychotherapy in Adults With Alcohol Use Disorder (AUD) Status UNKNOWN Phase PHASE2
NCT05624268 Efficacy, Safety, and Tolerability of COMP360 in Participants With TRD Status COMPLETED Phase PHASE3
NCT05562973 Safety and Tolerability of Psilocybin in Post-Traumatic Stress Disorder Status WITHDRAWN Phase PHASE1
NCT05557643 PAPR: PAP + MBSR for Front-line Healthcare Provider COVID-19 Related Burnout Status COMPLETED Phase PHASE1
NCT05554094 Psilocybin for the Treatment of Veterans With Post-Traumatic Stress Disorder Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05548075 Psilocybin in Patients With Fibromyalgia: EEG-measured Brain Biomarkers of Action Status ACTIVE_NOT_RECRUITING Phase N/A